Save time and get answers to complex questions with AI chat
Pramlintide approval date?Patent tenofovir alafenamide gilead?Alogliptin benzoate cost?Defense strategy against generic in niche market?When is tenofovir alafenamide patent expiring?
See the DrugPatentWatch profile for Axitinib
Axitinib (Inlyta) received FDA approval on January 27, 2012. [1]
At the time of approval, axitinib was indicated for advanced renal cell carcinoma (RCC) after failure of prior systemic therapy. [1]
You can verify the approval date on DrugPatentWatch.com’s drug page for axitinib. [1] Sources: [1] https://www.drugpatentwatch.com/p/axitinib
Other Questions About Axitinib :